Glucotrack | DEF 14A: Definitive information statements
Apr 1 15:53 ET
Glucotrack | 10-K: Annual report
Mar 28 16:41 ET
Glucotrack | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 22 17:08 ET
Glucotrack | 8-K: Current report
Feb 16 16:08 ET
Glucotrack | 8-K: Current report
Jan 11 00:00 ET
Glucotrack | SC 13G: Statement of acquisition of beneficial ownership by individuals
Jan 3 00:00 ET
Glucotrack | 8-K: Current report
Jan 2 00:00 ET
Glucotrack | 8-K: Current report
Nov 30, 2023 17:27 ET
Glucotrack: Q3 2023 Earnings Report
Nov 14, 2023 14:35 ET
Glucotrack | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Cardwell James S
Oct 18, 2023 19:13 ET
Glucotrack | 8-K: Current report
Oct 13, 2023 06:20 ET
Glucotrack | 8-K: Current report
Oct 12, 2023 17:23 ET
Glucotrack | 3: Initial statement of beneficial ownership of securities-Director Carter Erin Catherine
Sep 11, 2023 19:43 ET
Glucotrack | 8-K: Current report
Aug 31, 2023 17:18 ET
Glucotrack | 10-Q: Q2 2023 Earnings Report
Aug 14, 2023 16:45 ET
Glucotrack | 8-K: Current report
Jun 2, 2023 17:20 ET
Glucotrack | 8-K: Current report
May 19, 2023 16:45 ET
Glucotrack | 10-Q: Q1 2023 Earnings Report
May 12, 2023 16:50 ET
Glucotrack | 8-K: Current report
Apr 17, 2023 06:15 ET
Glucotrack | 424B5: Prospectus
Apr 17, 2023 06:01 ET
No Data
No Data